N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]-2-chloroacetamide
Structure Info
- Chemspace ID
- CSSB01898062527 (In-Stock Building Blocks)
- IUPAC Name
- N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]-2-chloroacetamide
- Mol formula
- C10H8BrClN2O2
- Mol weight
- 304 Da
- Catalog Number(s)
- BBLS01898062527, CSCR01898062527, EN300-45436674, Z3766269879, bbls01898062527
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.64
- Heavy atoms count
- 16
- Rotatable bond count
- 3
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.2
- Polar surface area (Å)
- 55
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]-2-chloroacetamide (C10H8BrClN2O2) - CSSB01898062527](/st/structure/200/057908644fb27adb5b7e579a388d90c4/ClCC%2528%253DO%2529NCC1%253DNC2%253DCC%253DC%2528Br%2529C%253DC2O1.png "C10H8BrClN2O2")
- Zoom the structure
- CSSB01898062527
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 828.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 868.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 906.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 946.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 986.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,931.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,858.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,236.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]-2-chloro-2-fluoroacetamide - CSSB21332054010](/st/structure/200/3b0c2358488f0b5eee915965f7e148ea/FC%2528Cl%2529C%2528%253DO%2529NCC1%253DNC2%253DC%2528O1%2529C%253DC%2528Br%2529C%253DC2.png)
Similarity Analogs
![Chemical structure of N-[(5-bromo-1,3-benzoxazol-2-yl)methyl]-2-chloroacetamide - CSSB01892606012](/st/structure/200/fe9de28471b8b60eb6678ffdd21649d4/ClCC%2528%253DO%2529NCC1%253DNC2%253DCC%2528Br%2529%253DCC%253DC2O1.png)
![Chemical structure of N-[(1,3-benzoxazol-2-yl)methyl]-2-chloroacetamide - CSSB00160546642](/st/structure/200/426fbcf5464f710e463118cab83a6784/ClCC%2528%253DO%2529NCC1%253DNC2%253DCC%253DCC%253DC2O1.png)
![Chemical structure of 2-chloro-N-[(5-chloro-1,3-benzoxazol-2-yl)methyl]acetamide - CSSB21332044614](/st/structure/200/785b9af34a981c943ad95eefa53e38d3/ClCC%2528%253DO%2529NCC1%253DNC2%253DC%2528O1%2529C%253DCC%2528Cl%2529%253DC2.png)
![Chemical structure of N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]prop-2-enamide - CSSB01994855279](/st/structure/200/0df570a60a87bcb163bcb2ef2d7778bf/C%253DCC%2528%253DO%2529NCC1%253DNC2%253DCC%253DC%2528Br%2529C%253DC2O1.png)
![Chemical structure of benzyl N-[(6-bromo-1,3-benzoxazol-2-yl)methyl]carbamate - CSSB03496571069](/st/structure/200/39ac01a12624fcfecd4f28b729b97d47/BrC1%253DCC%253DC2N%253DC%2528CNC%2528%253DO%2529OCC3%253DCC%253DCC%253DC3%2529OC2%253DC1.png)
